poloxalene has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Başak Türkmen, N; Beker, MÇ; Çağlayan, AB; Dede, B; Demirci, S; Doğan, A; Kiliç, E; Özkan, F; Şahin, F; Telci, D | 1 |
1 other study(ies) available for poloxalene and Prostatic Neoplasms, Castration-Resistant
| Article | Year |
|---|---|
Poloxamer P85 increases anticancer activity of Schiff base against prostate cancer in vitro and in vivo.
Topics: Animals; Cell Line, Tumor; Coordination Complexes; Gene Expression; Humans; Male; Mice, Inbred C57BL; Poloxalene; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Schiff Bases | 2017 |